Primary Liver Cancer
Primary liver cancer, also known as hepatocellular carcinoma (HCC), is a type of cancer that originates in the liver cells. It can lead to symptoms such as weight loss, abdominal pain, jaundice, and swelling in the abdomen.
Liver Cancer: Hyperpolarized Pyruvate MRI Study
We are exploring whether a new MRI technique can help detect small liver tumors earlier in people at risk for hepatocellular carcinoma. This may improve early diagnosis and treatment options.
>2 years≤5 visitsEfficacy phase (II)No PlaceboCost ReimbursementInvestigational MedicinesInjectionHepatologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 85 years old?
- Are you a pre-menopausal woman who is not pregnant?
- Do you have chronic kidney disease?
- Do you have significant heart problems like heart failure?
- Do you have significant lung disease or severe asthma?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Hyperpolarized pyruvate
Pyruvic acid
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Aarhus Universitetshospital
Aarhus University Hospital, Hepatology
Århus, Denmark
Sponsor: Aarhus Universitet
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.